Intravenous Thrombolysis with Urokinase for Acute Cerebral Infarctions: The Study Group of a 5-Year National Project of the People's Republic of China

Completed

Phase N/A Results

Summary of Purpose

To evaluate the efficacy and safety of urokinase (UK) in the treatment of acute cerebral infarctions within 6 hours from the onset of stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Multicenter, randomized, double-blind, placebo controlled clinical study.

Contacts

Not available